Risperidone Antagonism of Self-mutilation in a Lesch-Nyhan Patient

Overview

Journal Prog Neuropsychopharmacol Biol Psychiatry

Specialty Psychiatry

Date 1996 Jul 1

PMID 8870064

Citations 7

Authors

S M Allen

S N Rice

Affiliations

Soon will be listed here.

Abstract

1. The case is described of a 28-year old male with a diagnosis of Lesch-Nyhan syndrome. 2. Chronic treatment with the atypical neuroleptic risperidone at 4 mg daily has maintained a significant reduction in occurrence of self-mutilation.

Citing Articles

Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

Bremova-Ertl T, Hofmann J, Stucki J, Vossenkaul A, Gautschi M Cells. 2023; 12(18).

PMID: 37759536 PMC: 10527548. DOI: 10.3390/cells12182314.

Single-Electrode Deep Brain Stimulation of Bilateral Posterolateral Globus Pallidus Internus in Patients With Medically Resistant Lesch-Nyhan Syndrome.

Baird-Daniel E, Glaser A, Boop S, Durfy S, Hauptman J Cureus. 2023; 15(4):e37070.

PMID: 37153246 PMC: 10155820. DOI: 10.7759/cureus.37070.

Deep brain stimulation in Lesch-Nyhan syndrome: a systematic review.

Deng H, Xiong B, Wu Y, Wang W Neurosurg Rev. 2023; 46(1):40.

PMID: 36694014 DOI: 10.1007/s10143-023-01950-4.

Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients.

Li L, Qiao X, Liu F, Wang J, Shen H, Fu H Front Genet. 2022; 13:868942.

PMID: 35559039 PMC: 9086273. DOI: 10.3389/fgene.2022.868942.

Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

Bell S, Kolobova I, Crapper L, Ernst C Mol Syndromol. 2016; 7(6):302-311.

PMID: 27920633 PMC: 5131334. DOI: 10.1159/000449296.